Steatotic Liver Disease in Younger Adults is Associated With Altered Gut Microbiology

Yasmina Tashkent, Jocelyn M Choo, Alyson Richard, Zhengyi Wang, Luis Calzadilla-Bertot, Egi Vasil, Sophie Miller, Steven L Taylor, Kerry L Ivey, Richard Woodman, Brendan Adler, Oyekoya T Ayonrinde, John K Olynyk, Lawrence J Beilin, Trevor A Mori, Alan J Wigg, Kate R Muller, Leon A Adams, Geraint B Rogers

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)

Abstract

BACKGROUND AND AIMS: Steatotic liver disease (SLD) is a leading cause of chronic liver disease worldwide. As SLD pathogenesis has been linked to gut microbiome alterations, we aimed to identify SLD-associated gut microbiome features early in SLD development by utilising a highly characterised cohort of community-dwelling younger adults.

METHODS AND RESULTS: At age 27 years, 588 participants of the Raine Study Generation 2 underwent cross-sectional assessment. Hepatic steatosis was quantified using a validated magnetic resonance imaging (MRI) volumetric liver fat fraction (VLFF) equation (HepaFat). Of the 588 participants, 488 (83%) were classified as having 'no SLD' (VLFF ≤ 3.55%), 76 (12.9%) with 'mild-moderate' SLD (VLFF: 3.56%-13.4%) and 24 (4.10%) with 'severe' SLD (VLFF > 13.4%). Stool microbiome profiling identified an association between severe SLD and lower microbiota alpha diversity (observed features [p = 0.015], Pielou evenness [p = 0.001] and Shannon diversity [p = 0.002]) compared to no SLD. Faecal microbiota composition differed significantly between no SLD and both mild-moderate (p = 0.004) and severe SLD groups (p = 0.001). There was no significant difference in microbiota dispersion between SLD groups. Reduced relative abundance of short-chain fatty acid producing bacteria, and higher levels of proinflammatory bacterial taxa, were both significantly associated with severe SLD (q < 0.05).

CONCLUSIONS: SLD in younger adults is associated with reduced intestinal microbial diversity and a pattern of bacterial taxa depletion that is consistent with other chronic inflammatory conditions. Our characterisation of gut microbiome characteristics in early SLD development provides a potential basis for risk identification and reduction.

TRIAL REGISTRATION: The Raine Study is registered in the Australian New Zealand Clinical Trials Registry (ACTRN12617001599369).

Original languageEnglish
Article numbere70032
Number of pages13
JournalLiver International
Volume45
Issue number3
DOIs
Publication statusPublished - Mar 2025

Fingerprint

Dive into the research topics of 'Steatotic Liver Disease in Younger Adults is Associated With Altered Gut Microbiology'. Together they form a unique fingerprint.

Cite this